New Horizons: Finally, Approaches to Treating Moderate-to-Severe Atopic Dermatitis and Implications for Asthma

Mark Boguniewicz, MD, completed his residency in pediatrics at Children's Hospital of Michigan, Detroit, Michigan, and a fellowship in allergy-immunology and rheumatology at Children's Hospital and Harvard Medical School in Boston, Massachusetts. He is board certified in pediatrics and allergy-immunology.

Dr Boguniewicz is professor in the Division of Allergy-Immunology, Department of Pediatrics, at National Jewish Health and University of Colorado School of Medicine in Denver, Colorado. He is a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI), past chair of the Dermatologic and Ocular Diseases Interest Section, and past chair of the Eczema Committee. He is also a fellow of the American College of Allergy, Asthma and Immunology (ACAAI). He is on the editorial board of Journal of Allergy and Clinical Immunology: In Practice. He served on the Joint Task Force on Topical Calcineurin Inhibitors of the AAAAI and ACAAI, and he was co-chair of the treatment section of the European Academy of Allergology and Clinical Immunology/AAAAI/PRACTALL Consensus Group for atopic dermatitis. He has served on the Joint Task Force of the AAAAI/ACAAI for the 2004 and 2012 Practice Parameter for Atopic Dermatitis.

Dr Boguniewicz's research focuses on immunopathogenesis and new treatments for atopic dermatitis. He is an investigator in the National Institutes of Health Atopic Dermatitis Research Network. He has lectured at many national and international meetings, and he has published more than 300 peer-reviewed articles, reviews, chapters and abstracts. He is the recipient of the 1998–1999, 2010–2011, 2011–2012, and 2012–2013 Pediatric Allergy-Immunology Fellows Outstanding Teacher Award, the 2002 Faculty Clinician of the Year Award, and the 2006 AAAAI's Richard S. Farr Memorial Lectureship. He has been selected for Best Doctors in America from 2003 through 2016. He is also the recipient of the 2013 AAAAI Distinguished Clinician Award.

Jonathan Silverberg, MD, PhD, MPH, is an assistant professor in the Departments of Dermatology, Preventive Medicine, and Medical Social Sciences at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr Silverberg is the director of the Northwestern Medicine Multidisciplinary Eczema Center and founded the Multidisciplinary Eczema Clinic at Northwestern Medicine. He is also the director of the contact dermatitis clinic and photobiologic testing at Northwestern Memorial Hospital, which provides comprehensive evaluation and management of skin allergies and photosensitivity. He was the recipient of the Georg Rajka Medal from the International Society of Atopic Dermatitis, the Teacher of the Year Award in the Department of Dermatology at Northwestern Memorial Hospital, and the Everett C. Fox Research Award from the American Academy of Dermatology.

Dr Silverberg completed both his medical degree and master of public health degree in 2009 at State University of New York, Downstate Medical Center in Brooklyn, New York. His master's thesis focused on the protective role of herpesviridae on atopic dermatitis and other allergic disorders as part of the broader "hygiene hypothesis." He completed his doctorate in 2006 with thesis studies in neuroimmunology focused on murine immune responses after a seizure. He performed his residency training at St. Luke's-Roosevelt Hospital Center at Columbia University in New York City, New York.

His research goals are to better understand the risk factors and medical comorbidities of atopic dermatitis in the U.S. population. Dr Silverberg has authored 141 scientific articles and book chapters, including studies of the epidemiology of atopic dermatitis and "big data" research. He has extensive experience with database development, instrument development and deployment, and statistical programming.

Dr Silverberg is an associate editor for the British Journal of Dermatology and Current Dermatology Reports and is on the editorial board of Cutis. He is a member of the National Eczema Association Scientific Advisory Committee and American Academy of Dermatology Atopic Dermatitis Expert Resource Group, and he is chair of the Society of Investigative Dermatology Atopic Dermatitis Epidemiology Working Group. He is also a member of the Alpha Omega Alpha honor society, American Academy of Dermatology, Society of Investigative Dermatology, American Contact Dermatitis Society, Illinois Dermatologic Society, and Chicago Dermatologic Society.

Linda Stein Gold, MD, earned her undergraduate degree at the Wharton School of the University of Pennsylvania in Philadelphia, Pennsylvania, and her medical degree at the University of Pennsylvania School of Medicine. She completed her residency in dermatology at Henry Ford Hospital in Detroit, Michigan.

Dr Stein Gold is director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan, as well as division head of Dermatology at Henry Ford Health System in West Bloomfield, Michigan.

Dr Stein Gold is active in clinical research on a variety of dermatologic conditions, including the treatment of chronic plaque-type psoriasis, actinic keratosis, atopic dermatitis, acne vulgaris, seborrheic dermatitis, and rosacea. She has published articles in journals such as the Journal of the American Academy of Dermatology, Cutis, and the Journal of Drugs in Dermatology, among others. She is a frequent national and international lecturer on acne, rosacea, psoriasis, actinic keratosis, alopecia, viral infections, atopic dermatitis, and fungal infections at grand rounds and medical society meetings. She has been on the medical board of the National Acne and Rosacea Society and the National Psoriasis Foundation medical board. She is a member of the board of directors of the American Academy of Dermatology.